Write in a clean editor, then format for American Heart Journal Plus Cardiology Research and Practice in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
American Heart Journal Plus Cardiology Research and Practice is a peer-reviewed journal published by Elsevier, covering Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Heart Failure Treatment and Management.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, American Heart Journal Plus Cardiology Research and Practice 12 (2023) 45–58.
Formats any DOI in American Heart Journal Plus Cardiology Research and Practice style. No sign-up. |
| Publishes research in | Cardiac Imaging and Diagnostics Acute Myocardial Infarction Research Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Atrial Fibrillation Management and Outcomes |
| ISSN | 2666-6022 |
| Citation impact (2-yr) | 1.25 |
| h-index | 22 |
| i10-index | 71 |
| Total citations | 2,955 |
| Article processing charge | $2,650 |
| Open access | Yes |
| Top institutions publishing here | University of Florida |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms >3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is…
The COVID-19 pandemic has affected millions of patients across the globe. Multiple studies, national and international governmental data have shown important sex and gender differences in the incidence and outcomes of patients with COVID-19. These differences are not only attributed to the differences in age and comorbid conditions but likely a combination of factors, including…
Growth differentiation factor-15 (GDF-15) is a cytokine upregulated in multiple pathological conditions where oxidative stress, endothelial dysfunction, tissue aging, and chronic inflammation are the hallmarks. GDF-15 has many sources of production, including cardiac and vascular myocytes, endothelial cells, adipocytes and macrophages in response to metabolic stress, oncogenic transformation and the burden of proinflammatory cytokines or…
Heart failure is a significant public health burden that differentially impacts women. Important sex- and gender-based differences in HF risk factors, presentation, and treatment exist, and the generation of high-quality evidence is critical to elucidate these differences. Despite the remarkable growth of the heart failure clinical research enterprise over the last four decades, women remain…
Cardiovascular disease is a leading cause of death among cancer survivors, second only to cancer recurrence or development of new tumors. Cardio-oncology has therefore emerged as a relatively new specialty focused on prevention and management of cardiovascular consequences of cancer therapies. Yet challenges remain regarding precision and accuracy with predicting individuals at highest risk for…
